Brisbane Clinic for Lymphoma, Myeloma and Leukaemia,

Greenslopes, Queensland 4120

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non Hodgkin Lymphoma

Studies at this site

• Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL) — Completed
• Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas — Stopped early